Artia Global Partners LP Q2 2025 Filing

Filed August 14, 2025

Portfolio Value

$415.6B

Holdings

35

Report Date

Q2 2025

Filing Type

13F-HR

All Holdings (35 positions)

#StockSharesValue% PortfolioType
1
VRNAVERONA PHARMA PLC
1,016,004$96.1B23.12%Put
2
IM8NINSMED INC
792,712$79.8B19.19%Call
3
ARGXARGENX SE
78,311$43.2B10.39%
4
SLNOSOLENO THERAPEUTICS INC
494,424$41.4B9.97%
5
LLYELI LILLY & CO
30,700$23.9B5.76%
6
BSXBOSTON SCIENTIFIC CORP
155,200$16.7B4.01%
7
MRUSMERUS N V
296,750$15.6B3.76%
8
DGXQUEST DIAGNOSTICS INC
81,717$14.7B3.53%
9
AZNASTRAZENECA PLC
190,752$13.3B3.21%
10
XBISPDR SER TR
100,000$8.3B2.00%Put
11
TRVITREVI THERAPEUTICS INC
1,311,840$7.2B1.73%
12
ALNYALNYLAM PHARMACEUTICALS INC
20,970$6.8B1.65%
13
UGLPROSHARES TR II
168,000$5.8B1.40%Call
14
REGNREGENERON PHARMACEUTICALS
10,671$5.6B1.35%
15
SRRKSCHOLAR ROCK HLDG CORP
126,285$4.5B1.08%
16
RVMDREVOLUTION MEDICINES INC
104,190$3.8B0.92%
17
SWTXSPRINGWORKS THERAPEUTICS INC
63,930$3.0B0.72%
18
EYPTEYEPOINT PHARMACEUTICALS INC
316,700$3.0B0.72%
19
ABBVABBVIE INC
14,500$2.7B0.65%
20
VKTXVIKING THERAPEUTICS INC
96,479$2.6B0.62%
21
ASNDASCENDIS PHARMA A/S
12,240$2.1B0.51%
22
TGTXTG THERAPEUTICS INC
54,515$2.0B0.47%
23
VRTXVERTEX PHARMACEUTICALS INC
4,400$2.0B0.47%
24
RAREULTRAGENYX PHARMACEUTICAL IN
41,830$1.5B0.37%
25
UTHUNITED THERAPEUTICS CORP DEL
5,000$1.4B0.35%
26
MREOMEREO BIOPHARMA GROUP PLC
475,361$1.3B0.31%
27
PTGXPROTAGONIST THERAPEUTICS INC
22,951$1.3B0.31%
28
XENEXENON PHARMACEUTICALS INC
40,000$1.3B0.30%
29
BHVNBIOHAVEN LTD
80,000$1.1B0.27%
30
RNAAVIDITY BIOSCIENCES INC
34,600$982.6M0.24%
31
KNSAKINIKSA PHARMACEUTICALS INTL
29,200$808.0M0.19%
32
MLYSMINERALYS THERAPEUTICS INC
41,100$556.1M0.13%
33
NAMSNEWAMSTERDAM PHARMA COMPANY
27,319$494.7M0.12%
34
JANXJANUX THERAPEUTICS INC
20,000$462.0M0.11%
35
TVTXTRAVERE THERAPEUTICS INC
30,900$457.3M0.11%